Back to VANGUARD GROUP INC VANGUARD GROUP INC

BTAIBTAI
4 quarters

Position history for VANGUARD GROUP INCVANGUARD GROUP INC's holdings in BIOXCEL THERAPEUTICS INC

VANGUARD GROUP INC holds 292,753 shares of BTAI (BIOXCEL THERAPEUTICS INC), worth $468,405 as of 2025-Q4. The position was increased (+52.4% shares).

Current Value

$468,405

Current Shares

292,753

Total Value Change

+$430,192

Total Shares Change

+273,929

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Increased
292,753
+52.4%
$468,4050.0%$1.53
23
2025-Q3
Increased
192,125
+920.6%
$491,8400.0%$2.62
26
2025-Q2
Unchanged
18,824
0.0%
$34,0710.0%$1.77
0
2025-Q1
New
18,824
-
$38,2130.0%$2.12
31

Other major holders of BTAI: MILLENNIUM MANAGEMENT LLC, OAKTREE CAPITAL MANAGEMENT LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used